Organigram outlines profitable growth as Organigram stock is valued at USD 132.5 million
Published on 10/05/2026 at 19:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Organigram Global outlined a profitable-growth strategy while Organigram stock carried a USD 132.5 million market capitalization as of October 5, 2026. At the September 30, 2026 investor session, management emphasized higher margins, tighter spending and stronger cash generation, according to MarketBeat.
Revenue reaches CAD 105.8 million
Organigram reported gross revenue of CAD 145.1 million for the third quarter of fiscal 2026, up 32.00 percent from the prior-year period. Net revenue rose 49.00 percent to CAD 105.8 million, according to Business Wire.
The third quarter ended June 30, 2026, and included the first full quarter of Sanity Group consolidation. The combination shifted approximately 35.00 percent of revenue to international markets, while Sanity contributed nearly CAD 40 million of quarterly net revenue, according to MarketBeat.
Sanity changes the growth mix
Management is concentrating Canadian investment on SHRED, BOXHOT and Big Bag O' Buds while reducing lower-margin wholesale activity. The strategy links Canadian brand strength with Germany, which management described as the near-term international growth market, according to MarketBeat.
Organigram said manufacturing improvements are intended to lower costs and expand capacity. The company also expects positive free cash flow in the fourth quarter of fiscal 2026 and expects fiscal 2026 revenue to exceed CAD 350 million, according to the Q3 fiscal 2026 earnings call transcript published by Yahoo Finance.
Market value and next report
Organigram is listed on the NASDAQ Global Select Market and the TSX under OGI, and its fiscal year ends September 30, according to the company's investor-relations page. Zacks lists December 15, 2026, as the expected next earnings release date and shows a consensus estimate of USD 0.02 for earnings per share for the quarter ending September 2026, according to Zacks.
For investors, the key test is whether the Sanity-led revenue expansion converts into cash generation. The comparison is clear: third-quarter net revenue grew 49.00 percent year over year, while the fiscal 2026 plan now depends on revenue above CAD 350 million and positive fourth-quarter free cash flow.
Organigram stock market value
Organigram stock had a market capitalization of USD 132.5 million as of October 5, 2026. The company remains positioned between a CAD-led Canadian cannabis business and a growing European medical-cannabis platform, with the latest operating figures making margin and cash conversion the central measures for the next report.
Organigram Global stock facts
- Company: Organigram Global Inc.
- Ticker: OGI
- Primary exchange: NASDAQ Global Select Market
- Market capitalization: USD 132.5 million (as of October 5, 2026)
- Sector / Industry: Cannabis
- Next earnings date: December 15, 2026
